
From striving to increase sales to recognizing the need for larger facilities, growth is often on the minds of business owners. If you’re a business owner who set out to grow your Maryland business in 2017, use the infographic below as a guide.

From striving to increase sales to recognizing the need for larger facilities, growth is often on the minds of business owners. If you’re a business owner who set out to grow your Maryland business in 2017, use the infographic below as a guide.

Computers can classify skin cancers as successfully as human experts, according to the latest research attempting to apply artificial intelligence to health.
The US-based researchers say the new system, which is based on image recognition, could be developed for smartphones, increasing access to screening and providing a low-cost way to check whether skin lesions are cause for concern.

EVERY year about 120,000 organs, mostly kidneys, are transplanted from one human being to another. Sometimes the donor is a living volunteer. Usually, though, he or she is the victim of an accident, stroke, heart attack or similar sudden event that has terminated the life of an otherwise healthy individual. But a lack of suitable donors, particularly as cars get safer and first-aid becomes more effective, means the supply of such organs is limited. Many people therefore die waiting for a transplant. That has led researchers to study the question of how to build organs from scratch.

Redox, a Madison, WI-based integration platform for digital healthcare applications, closed a $9m Series B financing.
The round was led by RRE Ventures with participation from existing investors .406 Ventures, HealthX Ventures, and Flybridge Capital Partners.

Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced that it has entered into a definitive agreement to acquire GenVec, Inc. (NASDAQ: GNVC), a clinical-stage company and pioneer in the development of AdenoVerse™ gene delivery technology.

Last evening, during the 29th Annual Maryland Policy and Leadership Dinner, the Technology Council of Maryland, Inc. (TCM) and the Chesapeake Regional Tech Council (CRTC) announced a merger of the two organizations, effective immediately. The merger is designed to expand and regionalize Maryland’s technology and life science hubs, while also creating a consistent, unified voice for the industries statewide and a platform to attract more companies and leverage synergies.
“This is an exciting and obvious next step for our region—bringing together two powerhouse councils under one roof to benefit the tech and life science industries in our region,” said Tech Council of Maryland Chairman Rene B. LaVigne, President & Chief Executive Officer, Iron Bow Technologies. “We believe this will propel Maryland to become one of the elite hubs in the country for the life science and technology industries. We also believe that together, we will create a larger technology footprint in the region.”

Introducing The Medical Capital Innovation Competition to be held April 25-26, 2017 at the Global Center for Health Innovation, Cleveland OH in the HIMSS Innovation Center. Where innovators with big ideas on the collection, management, analysis and optimization of healthcare big data can submit their idea(s) and present their innovation.
With $100,000 in cash prizes, the competition will reward the best innovations with meaningful funding, mentoring, and potential access to three world class healthcare systems and collaborators who can turn big ideas into new big business realities. The Medical Capital Innovation Competition is open to and encourages participation from professional and collegiate teams.

The Greater Washington Partnership, a group of chief executives and business leaders from the Baltimore-Washington area, has tapped a former White House staffer as its CEO.
Jason Miller, who previously worked as deputy assistant to the President and Deputy Director of the National Economic Council, begins his tenure as CEO of the newly formed business group April 1.
“
John knows exactly what he’s doing and needs little management. He works rapidly but without any mistakes so he delivers an amazing amount of high quality work. No one can do what he does.”
This was the response I received when I asked a manager how John was doing. Sounds good, doesn’t it? Read on.

Dr. Patrick Soon-Shiong, an audacious biotech billionaire who has pledged to “solve health care,” has been in talks with the Trump administration about the possibility of serving in a senior role overseeing the US health care system, according to individuals familiar with the discussions.
Soon-Shiong, a trained surgeon, has met with President Trump and his advisers at least twice in recent weeks. During those discussions, he raised the possibility that he could serve as a “health care czar” with a broad portfolio in the administration as it seeks to reshape the health care system and replace the Affordable Care Act, according to two individuals, who spoke on the condition of anonymity.